Bausch Health Companies Inc. Common Stock (BHC) stock analysis

BHC · Bausch Health Companies Inc. Common Stock

Latest recorded price: USD 8.43

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

A reliable intrinsic value could not be calculated for BHC; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 8.1%, free cash flow margin 9.8%, ROIC 8.1%. The model flags 1 risk signal for this company.

Similar companies in Healthcare